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Abstract: Oxidative stress could help explain the relationship between childhood obesity and a
metabolically unhealthy (MU) status. Moreover, puberty could also influence this relationship,
since it entails physiological cardiometabolic changes. We aimed to evaluate plasma antioxidants
and oxidative stress biomarkers in MU and metabolically healthy (MH) prepubertal and pubertal
children and their associations with pro-inflammatory and endothelial damage biomarkers, taking
puberty into account. A total of 1444 Spanish children aged 3–17 years (48.9% males, 66% prepubertal,
47.1% with obesity) were recruited. Blood pressure, anthropometric and biochemical parameters
were measured, and children were categorized as having a MU or MH status according to risk factors.
Retinol, carotenes, tocopherols, total antioxidant capacity (TAC), oxidized low-density lipoprotein
and selected pro-inflammatory and endothelial damage biomarkers were analyzed. General linear
models adjusted for age, sex, recruitment center and body mass index, partial correlations and
stepwise linear regressions were performed. Lower carotenes and tocopherols levels were found in
MU than in MH children. Plasma TAC was lower in prepubertal and higher in pubertal children with
obesity compared to normal-weight children. Antioxidants and oxidative stress biomarkers showed
novel associations with several pro-inflammatory and endothelial damage biomarkers, with pubertal
differences, supporting the importance of considering both the antioxidant and oxidative stress status
and puberty in the prevention of metabolic diseases in childhood.
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1. Introduction
Overweight and obesity are increasing worldwide, having become important health issues in
childhood [1]. Sedentariness, low physical activity, and unhealthy diets are the greatest contributors to
this epidemic [2]. Obesity is frequently associated with the presence of hypertension, dyslipidemia,
and insulin resistance, which have been clustered under the term of metabolically unhealthy (MU) status.
However, there are also individuals with obesity who do not present any of these cardiometabolic
derangements, known as metabolically healthy (MH) [3]. Although there are several available
definitions of MU status, there is evidence that both childhood obesity and MU status increase
cardiovascular disease risk in adulthood [4,5]. Moreover, systemic inflammation and endothelial
damage have also been described in children with obesity [6,7], as well as increased oxidative
stress [8,9]. The relationship between oxidative stress, obesity, and cardiometabolic disease seems
to be a consequence of low-grade inflammation [10]. In addition, in the presence of excess weight,
a decreased antioxidant defense could further contribute to a higher cardiometabolic risk [11]. However,
these changes are often complex to detect, due to the homeostatic responses of the organism, as well as
to changes associated with childhood development, such as the onset of puberty [12]. Indeed, puberty
entails a physiological insulin resistance that influences oxidative stress and inflammation [13,14].
Furthermore, it could accelerate cardiometabolic alterations, since it has been observed that puberty
worsens endothelial dysfunction in young patients with type 1 diabetes [15]. Also, puberty reduces
insulin sensitivity and triggers hyperinsulinemia, both having a reciprocal relationship with endothelial
dysfunction [16]. Taken together, these findings show that puberty influences insulin resistance and
oxidative stress, known to contribute to the development and progression of cardiometabolic risk and,
particularly, endothelial damage [12].
Children and adolescents with obesity often follow inadequate diets, characterized by a low intake
of fruits and vegetables and high intake of sugars and fats, associated with a negative antioxidant
status [17–19]. Dietary vitamins such as carotenoids and tocopherols are of great interest as bioactive
compounds with antioxidant properties and potential positive effects on adipogenesis, lipid, and glucose
metabolisms [20,21], since they are involved in lipid metabolism and adipocyte differentiation [22].
Serum circulating concentrations of carotenes have been negatively associated with obesity [23] and
metabolic syndrome in children [11], and in adults and adolescents [24]. As for tocopherols, their levels
are lower in children with obesity, hypertension [25], and metabolic syndrome [11], and negatively
associated with body mass index (BMI), waist circumference (WC) [26], and C reactive protein (CRP)
plasma/serum levels [27]. Lower serum or plasma total antioxidant capacity (TAC) has also been
associated with metabolic syndrome in children, adolescents and adults [11,28]. In addition, increased
circulating oxidized low-density lipoproteins (ox-LDL) plasma levels have already been observed
in children with obesity [29]. However, most available studies to date have investigated individual
cardiometabolic alterations, type 1 diabetes, or obesity, without considering important aspects such
as puberty or studying its influence on their findings. In fact, pubertal children have shown higher
plasma levels of lipoperoxidation products than prepubertal children [14]. In addition, puberty has
been shown to influence endothelial function and blood antioxidant enzymes in patients with type
1 diabetes [15]. However, broader studies are required to investigate the close relationship between
puberty and antioxidant and oxidative stress biomarkers in terms of their impact on MU status risk,
understood as the presence of one or more cardiometabolic alterations (hypertension, hyperglycemia,
hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C) or insulin resistance; as well
as its association with inflammation and endothelial damage biomarkers.
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The aims of the present study were: (1) To analyze and compare circulating plasma concentrations
of retinol, carotenes, tocopherols, TAC, and ox-LDL in prepubertal and pubertal children, (2) to study
the association between a MH or MU status and circulating plasma concentrations of the mentioned
antioxidants and oxidative stress biomarkers, and (3) to analyze their potential associations with
biomarkers of inflammation and endothelial damage, in a group of Spanish children aged 3 to 17 years.
2. Materials and Methods
2.1. Population
A total of 1444 children (706 males and 738 females), aged 3 to 17 years, were recruited at three
Spanish Hospitals (Hospital Universitario Reina Sofía in Córdoba, Hospital Clínico Universitario in
Santiago de Compostela, and Hospital Clínico Universitario Lozano Blesa in Zaragoza) in the GENOBOX
case-control study [30]. Inclusion criteria were: Caucasian ethnicity, children and adolescents aged 3 to
17 and having normal-weight (controls) or overweight or obesity. Exclusion criteria were: Presence of
diabetes mellitus, presence of congenital, chronic, or inflammatory disease, psychomotor disability,
use of hormonal medication or other that modifies blood pressure, glucose or lipid metabolism, having
performed intense exercise in the 24 h previous to the examination, and/or having participated in a
research study in the previous three months. Written informed consent was obtained from parents or
caregivers, and children gave their assent, after fully explaining the study protocol. The study protocol
was approved by the local Ethics Committees of each participating hospital (Code IDs: Córdoba
01/2017, Santiago 1011/198, Zaragoza 10/2010). The study was performed according to the ethical
guidelines of the Edinburgh revision of Declaration of Helsinki (2000).
2.2. Clinical and Anthropometric Examination
Clinical features and Tanner stage according to puberty developmental signs were evaluated by
clinicians. From the studied population, 953 children were prepubertal (Tanner stage I) and 491 were
at higher pubertal stages (Tanner stages II–V) [31].
Weight and height were measured according to standard international procedures with the
children barefooted and in their underwear. BMI was calculated as height (m)/weight (kg)2. Children
where then categorized according to their BMI status as having normal-weight (406 children: 28.1%, of
which 53.7% were males), overweight (358 children: 24.8%, of which 41.6% were males) and obesity
(680 children: 47.1%, of which 49.9% were males) (Table S1), using the International Obesity Task Force
definition [32].
Blood pressure (BP) was measured from the non-dominant upper arm by a trained staff member
in a quiet, temperature-controlled room, using an automatic device (Omron M4-I Intellisense,
Omron Corporation, Osaka, Japan) after a 20-min rest. Three values were taken at 2-min intervals and
the average of the two closest measures was used for further analyses.
2.3. Blood Sampling
Blood samples were taken in a fasting state between 8:00 and 11:00 am and were centrifuged
immediately. Serum glucose, triacylglycerols (TAG), HDL-C and LDL cholesterol (LDL-C)
concentrations were measured in fresh samples using the clinical analysis system Roche Hitachi
Modular DPP (Roche, Basel, Switzerland). Fasting serum insulin was determined in fresh samples
using an Elecsys Modular E-170 (Roche, Basel, Switzerland). The Homeostasis Model Assessment
of Insulin Resistance (HOMA-IR) was calculated based on the published equation: HOMA-IR =
fasting glucose (mmol) × fasting insulin (µU/mL)/22.5 [33]. After centrifugation, plasma aliquots and
blood erythrocytes were separated and frozen at −80 ◦C until further analyses.
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2.4. Plasma Antioxidants and Ox-LDL Analysis
Measurement of plasma concentrations of retinol, carotenes and tocopherols were determined
after extraction with 1-propanol by ultra-high-pressure liquid chromatography coupled to mass
spectrometry (UHPLC-MS), using methanol 0.1% and isocratic formic as solvent, with a flow of
0.5 mL/min in a ACQUITY UPLCr BEH C18 50 mm column (internal diameter 2.1 mm and particle
size 1.7 µm) [34]. Concentrations were expressed in µg/dL for retinol and total carotenes, and in mg/dL
for total tocopherols. In addition, plasma carotenes and tocopherols ratio to TAG were also calculated.
Plasma TAC was determined using a commercial antioxidant assay kit (Cat no. 709001, Cayman
Chemical, Ann Arbor, MI, USA). Plasma ox-LDL (coefficient of variation [CV]: 7.8%) was determined
with an enzymatic immunoassay (Cat no. BI-20042, Biomedica Medizinprodukte GmbH & Co KG,
Vienna, Austria).
2.5. Plasma Pro-Inflammatory and Endothelial Damage Biomarkers Analysis
Plasma pro-inflammatory and endothelial damage biomarkers were measured using commercial
LINCOplex TM kits of human monoclonal antibodies (Linco Research, St. Charles, MO, USA) on
a Luminex® 200TM System (Luminex Corporation, Austin, TX, USA). Plasma active plasminogen
activator inhibitor-1 (aPAI-1) was measured with the HADK1-61K-A kit (CV: 6.6%). Interleukin (IL)-6
(CV: 7.8%), IL-8 (CV: 7.9%), monocyte chemoattractant protein 1 (MCP-1) (CV: 6%), hepatocyte growth
factor (HGF) (CV: 3%) and tumor necrosis factor alpha (TNFα) (CV: 7.8%) were measured using
the HADK2-61K-B kit. Myeloperoxidase (MPO) (CV: 12.3%), matrix metalloproteinase 9 (MMP-9)
(CV: 6.8%) and total PAI-1 (tPAI-1) (CV: 11.8%) were measured with the HCVD1-67 AK kit. High
sensitivity CRP (hsCRP) (CV: 4%) was determined by particle-enhanced turbidimetric immunoassay
(Dade Behring Inc., Deerfield, IL, USA).
2.6. Metabolic Health Definition
Children were classified in relation to the presence of a MU status according to the five published
criteria [7,35]: Systolic or diastolic BP ≥90th percentile for age, sex and height; glucose ≥100 mg/dL;
TAG >90th percentile for age, sex and race; HDL-C serum concentration <10th percentile for age and
sex; and elevated HOMA-IR, as described previously [7]. HOMA-IR cutoffs were ≥2.5 for prepubertal
children and ≥3.38 or ≥3.905 for pubertal males or females, respectively, these cutoffs were previously
obtained from the present population as described in [36] due to the absence of reference values [37].
A total of 767 children (47.5% males) fulfilled one or more criteria and were thus considered to have a
MU status (Tables S1 and S2).
2.7. Dietary Assessment
Food frequency consumption was evaluated with a qualitative food frequency questionnaire that
included common foods consumed in Spain. The children and their caregivers were interviewed,
and consumption frequency of each food item was recorded as never or hardly ever; once, 2–3, 4–6,
or >6 times per day; once, 2–4 or 5–6 times per week; and 1–3 times per month. Coded answers were
then converted into times per week and standardized Z-scores were obtained to use in further analyses.
Groups of individual foods high in carotenes (cooked and raw vegetables, fruit with and without
sugar and fruit juices) or tocopherols (nuts, seeds, vegetable oils and mayonnaise) were created by
summing their standardized values into new variables, according to the Spanish Food Composition
Database [38].
2.8. Statistical Analysis
Descriptive statistics, included evaluation of the distribution of continuous variables,
were evaluated using the Kolmogorov–Smirnov test and through visualization of histogram plots.
Non-normally distributed variables (aPAI-1, carotenes, carotenes/TAG, HGF, hsCRP, IL-6, IL-8, MCP-1,
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MMP-9, TNFα, and tocopherols/TAG, tPAI-1, ox-LDL) were ln-transformed for statistical analyses.
Student’s t-test was applied to evaluate differences in the descriptive characteristics of the participants.
General linear regression models adjusted by sex, age, recruitment center and BMI were used to
compare concentrations of antioxidant biomarkers, ox-LDL and standardized consumption frequency
of carotene and tocopherol-rich foods between the study groups (male vs. female, prepubertal
vs. pubertal, MH vs. MU, etc.). Partial correlations adjusted by age, sex, and BMI were used to
analyze the relationship between antioxidant biomarkers and ox-LDL among themselves and the rest
of studied biomarkers (cardiometabolic variables and biomarkers of inflammation and endothelial
damage). Finally, forward stepwise multiple regression analysis (including age, sex, recruitment center,
and BMI as confounders) were carried out to evaluate what antioxidant and oxidative stress biomarkers
(independent variables) could be considered as predictors of inflammatory risk and endothelial damage
(dependent variables).
3. Results
3.1. Antioxidant and Oxidative Stress Biomarkers in Prepubertal and Pubertal Children According to Metabolic
Health and Obesity
A description of the participants can be found in Appendix A and Supplementary Table S1.
Our analyses showed significantly higher TAC in pubertal compared to prepubertal children
independently of BMI (Table 1). Due to these observed differences between prepubertal and pubertal
children, as well as to the different cutoffs of the applied criteria to classify the children as MH or
MU, all subsequent analyses were stratified by pubertal status. Table 1 also shows the results of the
BMI-adjusted general linear models run to study the association between the different antioxidant and
oxidative stress biomarkers with MU status. We found significantly lower plasma tocopherols/TAG
and carotenes/TAG levels and higher ox-LDL concentrations in prepubertal MU compared with
MH children. Pubertal children with a MU status also showed lower concentrations of retinol,
tocopherols/TAG and carotenes/TAG concentrations than MH participants.




n Mean SD n Mean SD n Mean SD
Prepubertal
Retinol (µg/dL) 705 26.2 7.0 319 25.7 6.6 342 26.6 7.5 0.456
Carotene/TAG 104 705 20.31 19.77 319 25.97 21.94 342 14.07 12.61 0.000
Tocopherols/TAG 103 706 14.3 6.4 320 16.5 6.4 342 12.0 5.6 0.000
TAC (mM eq. Trolox) 781 1.95 ** 0.82 359 2.06 0.80 375 1.86 ** 0.81 0.336
Ox-LDL (mg/L) 579 1.95 1.88 288 1.86 1.90 259 2.01 1.81 0.002
Pubertal
Retinol (µg/dL) 279 30.9 8.6 102 31.6 8.6 168 30.3 8.6 0.048
Carotene/TAG 104 272 14.49 13.03 102 19.03 14.58 163 10.90 8.54 0.000
Tocopherols/TAG 103 277 12.9 6.1 102 15.4 6.6 168 11.1 5.1 0.000
TAC (mM eq. Trolox) 391 2.16 ** 0.90 169 2.07 0.80 209 2.25 ** 0.97 0.430
Ox-LDL (mg/L) 189 1.51 1.62 80 1.37 1.53 104 1.60 1.71 0.414
Mean and standard deviation (SD) of the studied biomarkers for children with MH or MU status, stratified by
pubertal status. p: Statistical significance of the general linear model (adjusted for sex, age, recruitment center
and BMI) for MU status (independent variable) and individual biomarkers (dependent variables). ** Statistical
significance (p < 0.01) of the general linear model (adjusted for sex, age, recruitment center, and BMI) between
prepubertal and pubertal children within each category (columns). Carotene/TAG, Tocopherols/TAG and ox-LDL
were ln-transformed for statistical analyses. BMI: body mass index; MH: metabolically healthy; MU: metabolically
unhealthy; ox-LDL: oxidized low-density lipoprotein; TAC: total antioxidant capacity; TAG: triacylglycerols.
We also evaluated the association between the assessed vitamins and oxidative stress markers
with obesity in order to corroborate previous findings. Differences in plasma biomarker concentrations
between children with normal-weight or overweight/obesity are shown in Table S3. We observed
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higher plasma retinol concentrations in prepubertal children with overweight/obesity compared
to normal-weight children, while plasma carotenes/TAG and tocopherols/TAG were significantly
lower in both prepubertal and pubertal children with overweight/obesity compared to normal-weight
children. TAC showed an opposite behavior in prepubertal and pubertal children, being significantly
lower in prepubertal and higher in pubertal overweight/obese children compared with their
normal-weight counterparts. No significant differences were observed for ox-LDL between children
with normal-weight or overweight/obesity.
Next, Figure 1 shows the plasma antioxidant vitamins and ox-LDL stratified according to MH/MU
status, weight categories (normal-weight, overweight, and obesity), and pubertal status. Plasma retinol
values (Figure 1a) vary within a narrow range and show significant differences between prepubertal
children with MH normal-weight compared to children with MU obesity. Regarding carotenes/TAG
(Figure 1b) and tocopherols/TAG (Figure 1c) ratios, the figure illustrates how obesity and MU status
display a cumulative effect in these antioxidant markers, which are at significantly lower values in
children with overweight or obesity and a MU status, both in prepubertal and pubertal children.
In addition, it can be observed how TAC (Figure 1d) behaves in an opposite manner in prepubertal vs.
pubertal children, which depends on weight rather than MU status. Finally, ox-LDL does not show
statistically significant differences among the compared groups (Figure 1e).Antioxidants 2020, 9, x FOR PEER REVIEW  
 
Figure 1. Mean values of plasma retinol (a), carotenes/TAG (b), tocopherols/TAG (c), TAC (d), and 
ox-LDL (e) of prepubertal and pubertal children, according to their weight categories 
(normal-weight, overweight, and obesity) and metabolic health (healthy or unhealthy) status. Within 
each pubertal category, different letters indicate significant differences at p < 0.05 in pairwise 
comparisons of the general linear model adjusted for sex, age and recruitment center, (sharing the 
same letters indicates no significant differences between groups, absence of letters indicates no 
significant differences between any of the groups). MH: metabolically healthy; MU: metabolically 
unhealthy; ox-LDL: oxidized low-density lipoprotein; TAC: total antioxidant capacity; TAG: 
triacylglycerols. 
3.2. Evaluation of the Dietary Sources of Carotenes and Tocopherols and Their Influence on Carotene/TAG and 
Tocopherol/TAG Levels 
Next, we compared the standardized consumption frequency of carotene- and tocopherol-rich 
foods between children with or without excess weight and MU status (Table 2). We observed a 
significantly lower consumption frequency of tocopherol-rich foods in MU compared with MH 
prepubertal children, independently of BMI and no differences in the consumption frequency of 
carotene-rich foods. The partial correlation analysis (adjusted by age, sex and BMI) between the 
consumption frequency of carotene or tocopherol-rich foods and plasma carotene/TAG and 
tocopherols/TAG concentrations, respectively, stratified by the children’s weight status 
(normal-weight, overweight, obesity) showed a positive association between the standardized 
consumption frequency of carotene-rich foods and plasma carotene/TAG concentrations (R = 0.367, p 
= 0.009) exclusively in normal-weight children, which was only confirmed in the pubertal group (R = 
0.727, p = 0.005) in the puberty-stratified analysis (data not shown). 
Figure 1. Mean values of plasma retinol (a), carotenes/TAG (b), tocopherols/TAG (c), TAC (d),
and ox-LDL (e) of prepubertal and pubertal children, according to their weight categories
(normal-weight, overweight, and obesity) and etabolic health (healthy or unhealthy) status. Within
each pubertal category, different letters indicate significant differences at p < 0.05 in pa rwise comparisons
of the general linear model djusted for sex, age and recruitment center, (sharing the same letters
indicates no significant differences between groups, absence of letters indicates no significant differences
between any of the groups). MH: metabolically healthy; MU: metabolically unhealthy; ox-LDL: oxidized
low-density lipoprotein; TAC: total antioxidant capacity; TAG: triacylglycerols.
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3.2. Evaluation of the Dietary Sources of Carotenes and Tocopherols and Their Influence on Carotene/TAG and
Tocopherol/TAG Levels
Next, we compared the standardized consumption frequency of carotene- and tocopherol-rich
foods between children with or without excess weight and MU status (Table 2). We observed a
significantly lower consumption frequency of tocopherol-rich foods in MU compared with MH
prepubertal children, independently of BMI and no differences in the consumption frequency of
carotene-rich foods. The partial correlation analysis (adjusted by age, sex and BMI) between
the consumption frequency of carotene or tocopherol-rich foods and plasma carotene/TAG and
tocopherols/TAG concentrations, respectively, stratified by the children’s weight status (normal-weight,
overweight, obesity) showed a positive association between the standardized consumption frequency
of carotene-rich foods and plasma carotene/TAG concentrations (R = 0.367, p = 0.009) exclusively in
normal-weight children, which was only confirmed in the pubertal group (R = 0.727, p = 0.005) in the
puberty-stratified analysis (data not shown).
Table 2. Standardized consumption frequency of carotene-rich and tocopherol-rich foods in
metabolically unhealthy and healthy children, by pubertal status.
Prepubertal Pubertal
MH MU MH MU
n Mean SD n Mean SD p n Mean SD n Mean SD p
Carotene-rich foods Z-score 122 −0.02 2.79 184 −0.16 2.47 0.738 122 −0.51 2.08 162 0.11 2.25 0.152
Cooked vegetables Z-score 122 0.08 1.10 184 −0.14 0.92 0.238 122 −0.17 0.74 162 0.15 1.06 0.024
Raw vegetables Z-score 122 −0.17 1.07 184 −0.11 0.91 0.968 122 −0.15 0.93 162 0.11 0.93 0.412
Fruit (no sugar) Z-score 122 −0.06 1.02 184 0.02 0.97 0.785 122 −0.14 0.93 162 0.10 1.09 0.220
Fruit (sugar) Z-score 122 0.01 0.93 184 0.06 1.10 0.811 122 −0.16 0.66 162 −0.07 0.83 0.464
Juices Z-score 122 0.11 1.02 184 0.02 1.00 0.790 122 0.12 1.08 162 −0.18 0.91 0.115
Tocopherol-rich foods Z-score 122 0.34 2.11 184 −0.18 1.91 0.018 122 0.04 1.84 162 0.14 1.77 0.354
Nuts + Seeds Z-score 122 0.14 1.06 184 −0.18 0.88 0.029 122 −0.05 1.00 162 0.13 1.04 0.120
Vegetable oils Z-score 122 0.10 1.00 184 −0.03 0.98 0.374 122 0.11 1.03 162 0.07 0.93 0.946
Mayonnaise Z-score 122 0.10 1.11 184 0.04 1.09 0.144 122 −0.03 0.89 162 −0.05 0.91 0.898
Mean and standard deviation (SD) of the standardized Z-score of the consumption frequency of foods rich in
carotenes and tocopherols for children with MH or MU status, stratified by pubertal status. p value indicates
statistical significance of the general linear model adjusted by sex, age, recruitment center and BMI. MH: metabolically
healthy; MU: metabolically unhealthy.
3.3. Exploring the Relationship between Antioxidants and Oxidative Stress Biomarkers and Cardiometabolic,
Pro-inflammatory and Endothelial Damage Markers
A partial correlation analysis was conducted to evaluate the relationship between antioxidant
and oxidative stress biomarkers among themselves (Table 3). As could be expected, carotenes/TAG
and tocopherols/TAG were strongly and positively correlated with each other (R > 0.500, p < 0.001) in
the total and puberty stratified analyses. Less strong correlations were observed between retinol and
tocopherols/TAG (R > 0.200, p < 0.001). Retinol and tocopherols/TAG were also negatively correlated
with ox-LDL when analyzing the total sample (p < 0.001).
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Table 3. Partial correlation analyses between analyzed plasma antioxidants and ox-LDL.
Retinol (µg/dL) Carotenes/TAG Tocopherols/TAG TAC (mM eq.Trolox)




Tocopherols/TAG 700 0.200 *** 700 0.532 ***
TAC (mM eq.Trolox) 574 −0.006 574 −0.011 574 0.010




Tocopherols/TAG 272 0.316 *** 266 0.598 ***
TAC (mM eq.Trolox) 182 −0.011 181 −0.011 182 −0.026
ox-LDL (mg/L) 181 −0.140 180 −0.261 *** 181 −0.187 * 184 −0.132
Total sample
Retinol (µg/dL)
Carotenes/TAG 971 0.075 *
Tocopherols/TAG 977 0.242 *** 971 0.548 ***
TAC (mM eq.Trolox) 761 −0.026 760 0.028 761 0.022
ox-LDL (mg/L) 758 −0.125 *** 757 −0.085 * 758 −0.131 *** 764 −0.012
Partial correlation adjusted for sex, age and body mass index in the total samples and separately by pubertal
stage, superscript letters indicate statistical significance (* p < 0.05, ** p < 0.01 y *** p < 0.001). All variables
were logarithmically transformed for analyses except retinol and TAC. ox-LDL: oxidized low-density lipoprotein;
TAC: total antioxidant capacity; TAG: triacylglycerols.
When studying the correlation between the analyzed antioxidants and oxidative stress biomarkers
and cardiometabolic variables (Table 4), we found a negative correlation between carotenes/TAG
and tocopherols/TAG and insulin and HOMA-IR (all R = −0.170, p < 0.01) in the total sample and
puberty-stratified analyses. Retinol was positively correlated with cholesterol and TAG in all analyses
(R > 0.140, p < 0.001). TAC was negatively correlated with SBP in the total sample (R = −0.087, p < 0.01)
and prepubertal children (R = −0.103, p < 0.01), negatively correlated with HDL-C in the total sample
(R = −0.86, p < 0.01) and pubertal children (R = −0.118, p < 0.05), and positively correlated with TAG in
the total sample (R = 0.087, p < 0.01) and pubertal children (R = 0.162, p < 0.01). (Table 4).
Finally, we examined the association between the analyzed antioxidants and oxidative stress
biomarkers and pro-inflammatory and endothelial damage biomarkers, in the total sample and
stratifying by pubertal stage. We first performed a partial correlation analysis to identify potential
associations between the studied biomarkers (Table S4). In view of the multiple observed associations,
we conducted a forward stepwise multiple regression analysis which results are shown in Table 5.
We found a strong positive association between ox-LDL and tPAI-1 in both the total and puberty
stratified analyses. Retinol was positively associated with MCP-1, TNFα, aPAI-1, and tPAI-1, and
negatively associated with hsCRP and MPO in prepubertal children, and in the total sample (with
slightly less significant associations). Similarly, carotenes/TAG values were negatively associated with
aPAI-1 and tPAI-1. Plasma tocopherols/TAG were positively associated with TNFα and plasma TAC
was negatively associated with MPO in prepubertal children and in the total sample. Concerning
significant associations in pubertal children, a strong positive association was found between TAC and
MCP-1 and TNFα, paralleled by a less significant positive association between ox-LDL and MCP-1.
Also, negative associations were observed between plasma tocopherols/TAG and IL-8 concentrations,
and between TAC and tPAI-1 in both pubertal children and the total sample.
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Table 4. Partial correlation analyses between plasma antioxidants and ox-LDL and metabolically unhealthy status components.
SBP (mm Hg) DBP (mm Hg) Glucose (mg/dL) Insulin (mU/L) HOMA-IR Chol (mg/dL) TAG (mg/dL) HDL-C (mg/dL)
n Corr. n Corr. n Corr. n Corr. n Corr. n Corr. n Corr. n Corr.
Prepubertal children
Retinol (µg/dL) 665 0.014 665 −0.051 700 0.063 673 0.075 673 0.071 700 0.206 *** 700 0.154 *** 690 −0.038
Carotenes/TAG * 665 −0.004 665 −0.021 700 −0.046 673 −0.223 *** 673 −0.210 *** 700 0.050 700 NA 690 0.288 ***
Tocopherols/TAG * 665 −0.052 665 −0.062 700 −0.095 * 673 −0.223 *** 673 −0.213 *** 700 0.030 700 NA 690 0.367 ***
TAC (mM eq.Trolox) 735 −0.103 ** 735 −0.031 775 0.046 740 −0.003 739 0.006 776 0.038 776 0.055 774 −0.057
ox-LDL (mg/L) * 544 0.056 544 0.074 577 0.051 555 −0.014 555 −0.013 577 0.022 577 0.062 575 −0.110 **
Pubertal children
Retinol (µg/dL) 266 0.023 266 0.099 273 0.022 270 0.050 270 0.045 272 0.231 *** 272 0.142 * 267 0.167 **
Carotenes/TAG * 259 −0.146 259 −0.050 266 −0.085 263 −0.170 ** 263 −0.171 ** 266 0.006 266 NA 261 0.285 ***
Tocopherols/TAG * 265 0.015 265 0.014 272 −0.094 269 −0.237 *** 269 −0.239 *** 272 0.039 272 NA 267 0.389 ***
TAC (mM eq.Trolox) 376 −0.063 376 −0.061 385 −0.023 377 0.009 376 0.002 386 0.026 386 0.162 ** 382 −0.118 *
ox-LDL (mg/L) * 179 0.009 179 −0.042 184 0.187 * 182 0.094 182 0.118 184 −0.068 184 0.065 183 −0.038
Total sample
Retinol (µg/dL) 936 0.036 936 0.012 978 0.071 * 948 0.057 948 0.055 977 0.217 *** 977 0.142 *** 962 −0.006
Carotenes/TAG * 929 −0.059 929 −0.050 971 −0.075 * 941 −0.189 *** 941 −0.185 *** 971 0.031 971 NA 956 0.285 ***
Tocopherols/TAG * 935 −0.041 935 −0.053 977 −0.113 *** 947 −0.236 *** 947 −0.233 *** 977 0.026 977 NA 962 0.357 ***
TAC (mM eq.Trolox) 1116 −0.087 ** 1116 −0.052 1165 0.014 1122 0.019 1120 0.020 1167 0.025 1167 0.087 ** 1161 −0.086 **
ox-LDL (mg/L) * 728 0.043 728 0.040 766 0.073 * 742 0.018 742 0.025 766 −0.002 766 0.059 763 −0.104 **
Partial correlation adjusted for sex, age and body mass index in the total samples and separately by pubertal stage, asterisks indicate statistical significance (* p < 0.05, ** p < 0.01,
*** p < 0.001). * Ln-transformed variable used for analyses. DBP: diastolic blood pressure; Chol: cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model
assessment for insulin resistance; NA: non-applicable; Ox-LDL: oxidized low-density lipoprotein; TAC: total antioxidant capacity; TAG: triacylglycerols; SBP: systolic blood pressure.
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Beta p Beta p Beta p Beta p Beta p Beta p Beta p Beta p Beta p Beta p
Prepubertal Children
Retinol (µg/dL) −0.149 1.2 × 10−5 0.087 0.049 - - - - 0.233 4.2 × 10−8 0.121 0.004 0.162 2.9 × 10−5 0.103 0.011 - - −0.166 7.3 × 10−5
Carotenes/TAG - - - - - - - - - - - - −0.096 0.044 −0.190 1.5 × 10−5 - - - -
Tocopherols/TAG - - - - - - - - - - 0.140 0.001 −0.087 0.059 - - −0.137 0.002 - -
TAC (mM eq.Trolox) - - - - - - - - - - - - - - - - - - −0.143 7.2 × 10−4
ox-LDL (mg/L) - - - - - - - - - - - - 0.097 0.010 0.265 6.5 × 10−11 - - - -
Pubertal children
Retinol (µg/dL) - - - - - - - - - - - - - - - - - - - -
Carotenes/TAG - - - - - - - - - - - - 0.093 0.003 - - - - - -
Tocopherols/TAG - - - - - - −0.319 5.2 × 10−5 - - - - - - - - 0.166 0.035 - -
TAC (mM eq.Trolox) - - - - 0.181 0.020 - - 0.367 8.6 × 10−7 0.281 6.9 × 10−5 - - −0.218 0.002 - - - -
ox-LDL (mg/L) - - 0.162 0.036 - - - - 0.163 0.022 - - - - 0.350 7.7 × 10−7 - - - -
Total sample
Retinol (µg/dL) −0.124 1.1 × 10−4 - - - - - - 0.200 1.4 × 10−7 0.075 0.045 0.094 0.007 - - - - −0.102 0.008
Carotenes/TAG - - - - - - - - - - −0.093 0.036 −0.162 9.2 × 10−6 −0.162 1.7 × 10−5 - - - -
Tocopherols/TAG - - - - - - −0.285 0.043 - - 0.121 0.005 - - - - - - - -
TAC (mM eq.Trolox) - - - - - - - - 0.158 7.9 × 10−6 0.095 0.006 - - −0.098 0.004 - - −0.116 0.002
ox-LDL (mg/L) - - - - - - - - 0.077 0.031 −0.069 0.050 0.094 0.005 0.265 3.1 × 10−14 0.100 0.006 - -
Stepwise multiple regression analyses were performed for each pro-inflammatory/endothelial damage biomarker (dependent variables) using sex, age, body mass index, center and the five
antioxidant/oxidative stress markers (independent variables), in the total samples and separately by pubertal stage. Standardized beta (beta) and significance value (p) are indicated for
those variables that remained in the models. All variables were logarithmically transformed for analyses except retinol, TAC and MPO. HGF: hepatocyte growth factor; hsCRP: high
sensitivity CRP; IL-6: interleukin 6; IL-8: interleukin 8; MCP-1: monocyte chemoattractant protein 1; MMP-9: matrix metalloproteinase 9; MPO: myeloperoxidase; Ox-LDL: oxidized
low-density lipoprotein; TAC: total antioxidant capacity; TAG: triacylglycerols; TNFα: tumor necrosis factor alpha; tPAI-1: total plasminogen activator inhibitor 1.
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4. Discussion
In the present study we aimed to evaluate differences in antioxidant and oxidative stress
biomarkers in MU compared with MH children according pubertal status, as well as their association
with pro-inflammatory and endothelial damage biomarkers. Our findings show that pubertal children
had higher plasma TAC values than prepubertal children, independently of BMI. We also observed lower
carotenes/TAG and tocopherols/TAG plasma values in prepubertal and pubertal MU children compared
to MH children, while ox-LDL concentrations were higher only in prepubertal MU children compared
to their healthy counterparts, independently of BMI. In addition, several significant associations
were found between the antioxidants and oxidative stress biomarkers and several biomarkers of
inflammation and endothelial damage.
4.1. Pubertal Differences in Antioxidant and Oxidative Stress Biomarkers in Children with Obesity or
MU Status
Our results support the existence of pubertal differences in the levels of selected biomarkers of
antioxidant and oxidative stress status in response against excess weight and MU status. According to
our findings, the prepubertal period appears as a more sensitive stage, in which plasma antioxidants
and TAC levels were negatively correlated with pro-inflammatory and endothelial damage biomarkers.
Thus, prepubertal children seem to be in a situation in which endothelial damage is taking place in
parallel to the lower antioxidant levels and higher ox-LDL, while responses against oxidative stress that
would increase TAC are not yet so evident. In this scenario, mechanisms contributing to endothelial
dysfunction include glucotoxicity, lipotoxicity, and inflammation [39]. Indeed, elevated free fatty acid
levels, present in individuals with diabetes, obesity or dyslipidemias may lead to lipotoxicity [40,41].
Inflammation is thought to act as a catalyst in cardiovascular disease, being able to enhance endothelial
damage [12].
In contrast, the pubertal period shows a different pattern. Indeed, most correlations found in
prepubertal children are changed in pubertal children, and different ones arise. These are mainly
observed for TAC and ox-LDL and mostly related to inflammation. It should be reminded that changes
occurring during puberty are closely related to oxidative stress and inflammation [42], which could
induce antioxidant defenses. A previous study performed in adolescents showed puberty to be related
to oxidative stress [14]. However, other studies have not found differences in antioxidant response
mechanisms between healthy children and adolescents [43,44]. Nevertheless, homeostatic responses
make difficult to conclude whether these children trigger or not a sufficient response against the
occurring alterations [45]. As already mentioned, puberty reduces insulin sensitivity and enhances
hyperinsulinemia, both leading to endothelial dysfunction [16]. It seems that the proinflammatory
state is more evident in pubertal children. However, larger longitudinal studies are needed to confirm
our preliminary findings and propose potential mechanisms, since there are few studies to date, with a
limited sample size.
4.2. Plasma Retinol Levels Are Decreased in Pubertal Children with MU Status and Correlated with
Pro-Inflammatory and Endothelial Damage Biomarkers
In accordance with a previous study [46], we have observed higher retinol plasma concentrations
in prepubertal children with obesity. A positive association between vitamin A and BMI, BMI-for-age,
waist–height ratio (WHR), and abdominal fat was found in Mexican school-aged children [27].
However, other authors observed lower serum retinol concentrations in children with obesity [47,48],
also associated negatively with BMI, WC, and glucose, and positively with HDL-C concentrations [48].
Moreover, we found significantly lower retinol plasma concentrations in pubertal MU children when
compared with their healthy counterparts. In contrast with previous studies that found no differences
or positive associations between retinol and metabolic syndrome (not MU status) in children and
adolescents, as reviewed by Beydoun et al., [24]. Similarly, a previous study also reported the
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association between retinol deficiency and hepatic steatosis in children [49]. Hence, the role of retinol
in cardiometabolic alterations remains unclear.
Concerning the potential role of retinol in cardiovascular risk, our study reveals interesting
findings. We observe significant associations between plasma retinol and several pro-inflammatory and
endothelial damage biomarkers, but mainly in prepubertal children. We found a negative correlation
between retinol and hsCRP and MPO in the prepubertal and total sample. Of these, the finding
regarding hsCRP is in accordance with previous studies in adults [50] and children [51], and the
correlation with MPO could be the first to be reported. However, we also observed positive associations
between retinol and MCP-1, aPAI-1, and tPAI-1 in the prepubertal and total samples that cannot
be explained.
4.3. Plasma Carotenes/TAG Levels Are Decreased in Children with Obesity or MU Status and Negatively
Correlated with Pro-inflammatory and Endothelial Damage Biomarkers, Insulin and HOMA-IR
Our results show a cumulative effect of obesity and MU status in the lowering of carotene/TAG
levels (Figure 1B). Indeed, carotene plasma levels have been previously found to be negatively
associated with obesity in children [11,23] and to anthropometric parameters (BMI, WC, FM) [47].
Specifically, plasma β-carotene levels were also inversely correlated with body weight but not to
plasma total lipids in children with obesity [52]. Available literature supports excess fat could be acting
as a trap for β-carotene, decreasing its circulating concentrations in obesity [53], which is in line with
the present data and may explain the lower plasma TAC observed in prepubertal children. Indeed,
we found a positive correlation between consumption frequency of carotene-rich foods and plasma
levels of carotenes/TAG, exclusively in normal-weight children. A previous study found no differences
in reported intake of β-carotene, α-tocopherol, fruit, or vegetables between children with or without
obesity [54], while other authors have described a significant correlation between fruit and vegetable
intake (carotenoids in diet) and plasma carotenoid concentrations in children only after adjusting for
BMI [55]. Compared with reference values [56], we found a high prevalence of carotene deficiency in
our studied population.
A potential interpretation of our findings is that the higher cardiometabolic risk could be a
consequence of the lower plasma carotenes availability, which could increase oxidation of circulating
lipids promoting endothelial damage. Accordingly, we observed for the first time a negative association
between carotenes/TAG and endothelial damage biomarkers aPAI-1 and tPAI-1. Plasma carotenes/TAG
were also negatively correlated with insulin and HOMA-IR, which agrees with a previous study that
showed serum β-carotene levels to be negatively correlated with glycaemia in adolescents with obesity
and MU status [57].
4.4. Plasma Tocopherols/TAG Levels Are Decreased in Children with Obesity or MU Status and Negatively
Correlated with Pro-inflammatory and Endothelial Damage Biomarkers, Insulin, and HOMA-IR
We also found lower tocopherol-rich foods consumption in prepubertal MU children compared
with MH children, independently of BMI, with no differences between children with or without
obesity, as previously reported [54]. A previous study has found plasma α-tocopherol to be negatively
associated with BMI and WC in children and adolescents with obesity [26]. However, beyond obesity,
our findings show an additional effect of MU status in the lower tocopherols/TAG levels, according to
previous data in children with metabolic syndrome [11]. In the present study, we found a negative
correlation of plasma tocopherols/TAG levels and insulin and HOMA-IR values. Similarly, vitamin
E corrected for plasma lipids was previously reported to be negatively associated with BMI, WHR,
abdominal fat, insulin and CRP (p < 0.05) in school-aged children [27]. However, we did not observe any
correlation with SBP, as previously reported in hypertensive adolescents [25]. Finally, tocopherols/TAG
levels were also negatively associated with IL-8 in the pubertal and total samples, and negatively
correlated with ox-LDL in all analyses. In contrast, tocopherols/TAG levels were positively associated
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with TNFα in prepubertal children and the total sample. To the best of our knowledge, this is the first
time these associations are observed in children.
4.5. Plasma TAC Levels Are Lower in Prepubertal and Higher in Pubertal Children with Obesity,
Not Influenced by MU Status and Positively Correlated with MCP-1 Plasma Concentration
In the present study, prepubertal and pubertal children show different patterns of results. We found
lower plasma TAC in prepubertal children with excess weight, which is in line with previous studies
reporting lower TAC in children with obesity aged 6–16 y [9] and 2–11 y [58]. But, in contrast, we found
higher TAC in pubertal children with overweight/obesity than in normal-weight participants. Similarly,
a previous study found higher serum total antioxidant status (TAS) in obese children aged 7–17,
which was not significantly correlated with BMI [8]. However, the observed differences for TAC were
absent when comparing MH and MU children in the BMI-adjusted analysis, maybe indicating the
influence of fat mass. According to our knowledge, this is the first study comparing plasma antioxidant
state between MH and MU children taking puberty into account. Therefore, more studies are needed
to confirm the present data.
Regarding the association analyses, our results show plasma TAC to be positively associated
with inflammatory biomarkers MCP-1 and TNFα, and negatively associated with the endothelial
damage biomarkers tPAI-1 (in the pubertal and total samples) and MPO (in the prepubertal and total
samples). This could be an additional hint on the differential responses observed in prepubertal and
pubertal children.
4.6. Plasma ox-LDL Levels Are Increased in Prepubertal MU Children and Positively Correlated with PAI-1
In the present study we have observed increased ox-LDL concentrations in prepubertal children
with MU status compared with their healthy counterparts. In line with this, increased levels of ox-LDL,
which play a key role in the development of atherosclerosis from early ages, have been consistently
found in children with obesity [29,59,60]. Also, ox-LDL have been associated with cardiometabolic
risk factors [61] and decreased after a 10-week weight loss program in children with obesity [62].
Consistently with these findings and for the first time, to our knowledge, we observed a strong positive
association between ox-LDL and tPAI-1 in all analyses. Indeed, previous studies have observed how
ox-LDL could activate PAI-1 transcription [63]. In addition, ox-LDL was also negatively correlated
with HDL-C, and positively correlated with plasma glucose in our population, further supporting the
role of this oxidative stress biomarker as an indicator of an unhealthy cardiometabolic status.
4.7. Prevention Strategies
Dietary total antioxidant capacity has been negatively associated to BMI and total body fat
only in children and adolescents with obesity [28]. In view of the present findings, the two
most straightforward strategies to overcome the increased risk of MU status are weight loss and
antioxidant supplementation [19]. Indeed, a weight loss intervention in adolescents was able to
increase lipid-corrected β-carotene and α-tocopherol plasma concentrations [52,64] and lead to
reduced ox-LDL levels in children with obesity [62]. Moreover, a physical activity program was also
able to lower endothelial dysfunction and oxidative stress markers in adolescents with metabolic
syndrome [65]. However, whereas in animal models, β-carotene supplementation has been shown to
reduce obesity, by leading to downregulation of adipogenic genes [66], randomized control trials have
not proven the usefulness of β-carotene supplementation in the prevention of metabolic syndrome.
Nevertheless, children with obesity lost weight after being supplemented with a carotenoid mixture [67],
while lycopene, a non-provitamin-A carotenoid, has been shown to reduce BP and oxidative stress
biomarkers in adults [68].
While antioxidant supplementation may lead to metabolic benefits [20,69–71], perhaps the use of
food items or dietary patterns rich in antioxidants would be a more appropriate approach to increase
circulating availability of carotenes or tocopherols [72,73]. However, there is not a clear dose–response
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effect, which suggests individual variability in biomarkers reflecting fruit and vegetable intake [73].
These facts support the need of future studies to investigate whether dietary patterns, i.e., Mediterranean
diet, and not individual nutrients, could help prevent MU status and its causing mechanisms.
4.8. Limitations and Strenghts
The present work has several limitations. First, since food consumption data were derived from a
qualitative food frequency questionnaire, the carotene and tocopherol content of the diet could not be
quantitatively determined. Also, the observational cross-sectional design does not allow to establish
causality of the findings. In addition, the use of fat mass of the participants instead of BMI could have
been of interest in order to adjust the analyses by this variable and should be considered in future
studies. Finally, other antioxidant molecules that could influence the findings regarding tocopherols,
such as Coenzyme Q10 and vitamin C, were not measured.
As for strengths, this is one of the first studies to analyze the effect of puberty on antioxidant and
oxidative stress biomarkers in a large sample of prepubertal and pubertal children. Also, we used
standardized data from geographically distant and different centers. Moreover, a large set of biomarkers
were analyzed, and children were carefully and individually examined by clinicians to determine their
Tanner stage. It is also important that we could include data regarding dietary habits.
5. Conclusions
In the present study we confirm the previously reported negative association between
carotenes/TAG and tocopherols/TAG and obesity and find, for the first time, a strong negative
association between MU status and carotenes/TAG and tocopherols/TAG, independently of BMI
and pubertal status. These results support the potential role of these antioxidants in obesity and its
complications. Moreover, differences due to pubertal status have been identified, highlighting the
lower antioxidant status, related with a worse profile of endothelial damage biomarkers, in prepubertal
children, whereas in pubertal children inflammation seems to be predominant.
The current data point to both the prepubertal and pubertal periods as important life stages for
oxidative and endothelial damage prevention and treatment, including the promotion of a healthy
and physically active lifestyle with a diet high in vitamin-rich foods, in order to avoid the onset and
progression of cardiometabolic derangement.
These findings support the need of considering puberty in future studies investigating the impact
of oxidative stress and antioxidant status in metabolic diseases in childhood, such as obesity or
insulin resistance.
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Appendix A
Descriptive characteristics of the participants according to sex and pubertal stage are shown in
Table S1. The observed plasma retinol and tocopherols concentrations fitted in the range of adequate
levels according to previous data, reported to be 20–65 µg/dL for retinol and 0.7–1.6 mg/dL for
tocopherols (Gil, 2017). However, our results indicate a highly prevalent deficiency of carotenes
(96.9% in normal-weight individuals and 100% in participants with overweight or obesity), for which
the reference is established to be >40 µg/dL. Prepubertal females were younger and showed lower
weight, height, BMI Z-score, HDL-C, fasting plasma glucose concentrations and tocopherols/TAG
ratio, and higher serum TAG and insulin concentrations and TAC values than prepubertal males.
At pubertal stage, females also showed lower height, SBP and plasma TAC values and retinol, MCP-1
and TNFα concentrations, and higher insulin and HOMA-IR values than males. Differences between
prepubertal and pubertal males were found in anthropometric values, SBP, TAG, fasting glucose, insulin,
HOMA-IR, retinol, TAC, aPAI-1 and tPAI-1, which were higher, and BMI Z-score, total cholesterol,
HDL-C, carotenes, carotenes/TAG, tocopherols/TAG, IL-6, MCP-1, TNFα and MMP-9, which were
lower in pubertal than in prepubertal males. The same differences were observed between prepubertal
and pubertal females, except for tocopherols/TAG, ox-LDL, hsCRP and IL-8, which were lower in
pubertal than prepubertal females and the BMI Z-score, total cholesterol, TAG, TAC, tPAI-1 and MMP-9
values, that were similar between pubertal and prepubertal females (Table S1).
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